| PASVR | pulmonary anomalous superior venous return |
|---|---|
| RNSC | radionuclide superior cavography |
| RSO | radiation safety officer; Resident Surgical Officer; right superior oblique [muscle] |
| RSR | regular sinus rhythm; relative survival rate; right superior rectus [muscle] |
| RSVC | right superior vena cava |
| thyroid nodule | A small circumscribed mass of differentiated tissue associated with the thyroid gland. It can be pathogenic or non-pathogenic. The growth of nodules can lead to a condition of goiter, nodular. most nodules appear between the ages of 30 and 50 years and most are benign. (12 Dec 1998) |
|---|---|
| thyroid receptor antibody | A test that measures the amount of an antibody (thyroid stimulating antibody) which is directed against a receptor for TSH on the thyroid gland. This antibody acts like TSH and stimulates the thyroid to produce excessive amounts of thyroid hormone. The presence of this antibody generally indicates Grave's disease (hyperthyroidism). (27 Sep 1997) |
| thyroid releasing hormone | <endocrinology> Thyroid releasing hormone (TRH) is a byproduct of the hypothalamus and serves to stimulate the pituitary gland to produce thyroid stimulating hormone (TSH). TRH is produced by the hypothalamus when thyroid hormone (T3 and T4) blood levels are low. (27 Sep 1997) |
| thyroid scan | A picture taken of the thyroid gland after radioactive iodine is taken by mouth. (12 Dec 1998) |
| thyroid stimulating antibody | <endocrinology, immunology> Long acting thyroid stimulator is an autoantibody found in many cases of primary thyrotoxicosis which causes hyperplasia of the thyroid by undetermined mechanisms. Human thyroid stimulating immunoglobulin is a different antibody found in all or nearly all cases of primary thyrotoxicosis and may act by binding to the thyrotropin (TSH) receptor site, causing increased synthesis of thyroglobulin. (18 Nov 1997) |
| thyroid stimulating hormone | <endocrinology> Polypeptide hormone (28 kD), secreted by the anterior pituitary gland, that activates cyclic AMP production in thyroid cells leading to production and release of the thyroid hormones (T4 and T3). T4 and T3 blood levels feedback on the pituitary gland and decrease thyroid stimulating hormone production when T3 and T4 levels are high. (27 Sep 1997) |
| thyroid-stimulating hormone | thyroid stimulating hormone |
| thyroid-stimulating hormone-releasing factor | <protein> See thyrotrophic releasing hormone. (18 Nov 1997) |
| thyroid-stimulating hormone stimulation test | TSH stimulating test, a test that measures the uptake of 131I in the thyroid gland before and after administration of thyroid-stimulating hormone; useful in distinguishing primary hyperthyroidism (increased TSH serum concentration) from secondary or tertiary hyperthyroidism (low TSH serum concentrations). (05 Mar 2000) |
| thyroid stimulating immunoglobulin | <protein> A test that measures the amount of an antibody (thyroid stimulating antibody) which is directed against a receptor for TSH on the thyroid gland. This antibody acts like TSH and stimulates the thyroid to produce excessive amounts of thyroid hormone. The presence of this antibody generally indicates Grave's disease (hyperthyroidism). (27 Sep 1997) |
| thyroid-stimulating immunoglobulins | In Graves' disease, the antibodies to TSH receptors in the thyroid gland. These antibodies are produced by B-lymphocytes and stimulate the receptors, causing hyperthyroidism. Formerly known as LATS (long-acting thyroid stimulator). (05 Mar 2000) |
| thyroid storm | A severe form of hyperthyroidism caused by excessive quantities of thyroid hormones. Thyrotoxicosis may occur as a complication of Grave's disease. Symptoms include weight loss, increased appetite, restlessness, heat intolerance, increased sweating, sleep difficulty, muscle cramps, fatigue, diarrhoea, thirst, muscle atrophy, bounding pulse, tremor, protruding eyes (exophthalmos), high blood pressure and menstrual irregularities. Death can result from congestive heart failure and pulmonary oedema. May be associated with goitre. (27 Sep 1997) |
| thyroid suppression test | A thyroid function test used to diagnose difficult cases of hyperthyroidism, now largely replaced by the thyrotropin-releasing hormone stimulation test; triiodothyronine is administered for a week to 10 days, and a reduction of its uptake by the thyroid gland to less than half of the initial uptake is a normal response. Synonym: Werner's test. (05 Mar 2000) |
| thyroid therapy | The treatment of hypothyroidism. (05 Mar 2000) |
| thyroid toxicosis | Hyperthyroidism resulting from excessive circulating 3,5,3'-triiodothyronine. Synonym: thyroid toxicosis. (05 Mar 2000) |